ARCHIVES

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

DeVita Seeks End to Funding For CROS, Reacts With Anger To Charge Of “Central Direction From Washington”

February 20, 1981

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005

Judge Rules Privacy Act Not Applicable In Bernard Fisher’s Suit Against HHA

July 5, 1996

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

Centers’ Problems Get Increasing Attention From Staff, Advisors

August 20, 1976

Cancer Policy: President’s Cancer Panel Issues Statement On National Cancer Program

September 17, 1999